MODERATE TO SEVERE ASTHMA
Clinical trials for MODERATE TO SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma shot aims to help patients breathe easier
Disease control Not yet recruitingThis Phase 2 trial tests an injectable drug called RC1416 in 195 adults with moderate to severe asthma that is not well controlled. Participants will receive either the drug or a placebo by injection. The study will measure changes in lung function and track asthma attacks over t…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill could help asthma sufferers breathe easier
Disease control Not yet recruitingThis study tests a new drug, linvemastat, for adults with moderate-to-severe asthma that is not fully controlled by standard inhalers. About 135 participants will receive either one of two doses of linvemastat or a placebo, while continuing their usual medications. Over 16 weeks,…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC